Literature DB >> 23467296

Components of the complete blood count as risk predictors for coronary heart disease: in-depth review and update.

Mohammad Madjid1, Omid Fatemi.   

Abstract

Atherosclerosis is an inflammatory disease, and several inflammatory biomarkers, such as C-reactive protein, have been used to predict the risk of coronary heart disease. High white blood cell count is a strong and independent predictor of coronary risk in patients of both sexes, with and without coronary heart disease. A high number of white blood cells and their subtypes (for example, neutrophils, monocytes, lymphocytes, and eosinophils) are associated with the presence of coronary heart disease, peripheral arterial disease, and stroke. The coronary heart disease risk ratios associated with a high white blood cell count are comparable to those of other inflammatory markers, including C-reactive protein. In addition, other components of the complete blood count, such as hematocrit and the erythrocyte sedimentation rate, also are associated with coronary heart disease, and the combination of the complete blood count with the white blood cell count can improve our ability to predict coronary heart disease risk. These tests are inexpensive, widely available, and easy to order and interpret. They merit further research.

Entities:  

Keywords:  Atherosclerosis; biological markers/blood; complete blood count; coronary artery disease; coronary heart disease; inflammation; leukocyte count; white blood cell count

Mesh:

Substances:

Year:  2013        PMID: 23467296      PMCID: PMC3568280     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  175 in total

1.  Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris. OPUS-TIMI 16 Investigators.

Authors:  C P Cannon; C H McCabe; R G Wilcox; J H Bentley; E Braunwald
Journal:  Am J Cardiol       Date:  2001-03-01       Impact factor: 2.778

2.  Influence of HMG-CoA reductase inhibitors on markers of coagulation, systemic inflammation and soluble cell adhesion.

Authors:  Christoph Bickel; Hans J Rupprecht; Stefan Blankenberg; Christine Espinola-Klein; Gerd Rippin; Gerd Hafner; Johannes Lotz; Winfried Prellwitz; Jürgen Meyer
Journal:  Int J Cardiol       Date:  2002-01       Impact factor: 4.164

3.  Which white blood cell subtypes predict increased cardiovascular risk?

Authors:  Benjamin D Horne; Jeffrey L Anderson; Jerry M John; Aaron Weaver; Tami L Bair; Kurt R Jensen; Dale G Renlund; Joseph B Muhlestein
Journal:  J Am Coll Cardiol       Date:  2005-04-25       Impact factor: 24.094

4.  New trends in coronary artery disease: the role of granulocyte activation.

Authors:  G Ricevuti; A Mazzone; S De Servi; G Specchia; P Fratino
Journal:  Atherosclerosis       Date:  1989-08       Impact factor: 5.162

5.  Effect of human recombinant interleukin-6 and interleukin-8 on monocyte procoagulant activity.

Authors:  F J Neumann; I Ott; N Marx; T Luther; S Kenngott; M Gawaz; M Kotzsch; A Schömig
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-12       Impact factor: 8.311

6.  Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality.

Authors:  R H Grimm; J D Neaton; W Ludwig
Journal:  JAMA       Date:  1985-10-11       Impact factor: 56.272

7.  Association between white blood cell count and risk factors of coronary artery disease.

Authors:  V Capuano; N Lamaida; M De Martino; G Mazzotta
Journal:  G Ital Cardiol       Date:  1995-09

8.  Association of circulating leukocyte count with coronary atherosclerosis regression after pravastatin treatment.

Authors:  Shigemasa Tani; Ken Nagao; Takeo Anazawa; Hirofumi Kawamata; Kiyoshi Iida; Michiaki Matsumoto; Yuichi Sato; Atsushi Hirayama
Journal:  Atherosclerosis       Date:  2008-02-16       Impact factor: 5.162

9.  White blood cell count is associated with macro- and microvascular complications in chinese patients with type 2 diabetes.

Authors:  Peter C Tong; Ka-Fai Lee; Wing-Yee So; Margaret H Ng; Wing-Bun Chan; Matthew K Lo; Norman N Chan; Juliana C Chan
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

10.  Leukocyte count and risk of major coronary heart disease events.

Authors:  A N Phillips; J D Neaton; D G Cook; R H Grimm; A G Shaper
Journal:  Am J Epidemiol       Date:  1992-07-01       Impact factor: 4.897

View more
  69 in total

1.  Do circulating blood cell types correlate with modifiable risk factors and outcomes in patients with acute coronary syndrome (ACS)?

Authors:  Kamal H Sharma; Komal H Shah; Iva Patel; Alap K Patel; Subhash Chaudhari
Journal:  Indian Heart J       Date:  2015-08-06

2.  Factors Associated with Multiple Biomarkers of Systemic Inflammation.

Authors:  Sandi L Navarro; Elizabeth D Kantor; Xiaoling Song; Ginger L Milne; Johanna W Lampe; Mario Kratz; Emily White
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-01-11       Impact factor: 4.254

3.  White blood count components as risk predictors for coronary heart disease: the role of eosinophils.

Authors:  George D Soufras; Grigorios Tsigkas; George Hahalis; Nicholas G Kounis
Journal:  Tex Heart Inst J       Date:  2014-02

4.  Lower mean corpuscular hemoglobin concentration is associated with poorer outcomes in intensive care unit admitted patients with acute myocardial infarction.

Authors:  Yuan-Lan Huang; Zhi-De Hu
Journal:  Ann Transl Med       Date:  2016-05

5.  Impact of red blood cells count on the relationship between high density lipoproteins and the prevalence and extent of coronary artery disease: a single centre study [corrected].

Authors:  Alon Schaffer; Monica Verdoia; Ettore Cassetti; Lucia Barbieri; Pasquale Perrone-Filardi; Paolo Marino; Giuseppe De Luca
Journal:  J Thromb Thrombolysis       Date:  2015-07       Impact factor: 2.300

Review 6.  Dynorphins in Development and Disease: Implications for Cardiovascular Disease.

Authors:  Cody Cissom; Jason J Paris; Zia Shariat-Madar
Journal:  Curr Mol Med       Date:  2020       Impact factor: 2.222

7.  Sp1-associated activation of macrophage inflammatory protein-2 promoter by CpG-oligodeoxynucleotide and lipopolysaccharide.

Authors:  K-W Lee; Y Lee; H-J Kwon; D-S Kim
Journal:  Cell Mol Life Sci       Date:  2005-01       Impact factor: 9.261

8.  The effect of eicosapentaenoic and docosahexaenoic acids on physical function, exercise, and joint replacement in patients with coronary artery disease: A secondary analysis of a randomized clinical trial.

Authors:  Abdulhamied Alfaddagh; Tarec K Elajami; Mohamad Saleh; Mohamad Elajami; Bruce R Bistrian; Francine K Welty
Journal:  J Clin Lipidol       Date:  2018-03-14       Impact factor: 4.766

9.  Predictive and prognostic value of admission neutrophil-to-lymphocyte ratio in patients with CHD.

Authors:  C Yu; M Chen; Z Chen; G Lu
Journal:  Herz       Date:  2016-03-08       Impact factor: 1.443

10.  Glucocorticoid treatment at moderate doses of SIVmac251-infected rhesus macaques decreases the frequency of circulating CD14+CD16++ monocytes but does not alter the tissue virus reservoir.

Authors:  Marcin Moniuszko; Namal P M Liyanage; Melvin N Doster; Robyn Washington Parks; Kamil Grubczak; Danuta Lipinska; Katherine McKinnon; Charles Brown; Vanessa Hirsch; Monica Vaccari; Shari Gordon; Poonam Pegu; Claudio Fenizia; Robert Flisiak; Anna Grzeszczuk; Milena Dabrowska; Marjorie Robert-Guroff; Guido Silvestri; Mario Stevenson; Joseph McCune; Genoveffa Franchini
Journal:  AIDS Res Hum Retroviruses       Date:  2015-01       Impact factor: 2.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.